Chávez-Torres R, Ruiz-Chávez J, Ruiz-Cruz E, Juárez-Naranjo E, Campos-Campos L, Villanueva-Padrón L, Horta-Martínez A, Montes-Castillo ML, Monroy-Hernández V, Hernández-Caballero E

Language: Spanish
References: 16
Page: 445-448
PDF size: 94.64 Kb.

ABSTRACT

Newborn was referred with diagnosis of neonatal epilepsy. Medical team could suspect and confirm D-bifunctional peroxisomal enzymatic deficiency diagnosis. It was made by family antecedents, severe neonatal hypotonia, uncontrolled neonatal seizures, craniofacial dysmorphic features, psychomotor retardation, neuronal migration defect and a positive peroxisomal panel. The full study in skin fibroblasts involved enzyme analysis, complementation studies and DNA analysis. The accumulation of very long chain fatty acids, partial deficiency in phytanic acid oxidation, and abnormal morphology of peroxisomes was consistent with a defect in peroxisomal fatty acid oxidation,involving D-bifunctional protein. It is very important to make a diagnosis of this innate error of metabolism in order to give preconceptional genetic counseling, to identify recurrence risk and to perform mutation analysis for the D-bifunctional protein gene, and to offer the prenatal diagnosis.

REFERENCES

1. López-Terradas JM. Introducción al estudio de las enfermedades peroxisomales. Rev Neurol 1999; 28(1):S34-S37.

2. Möller G, van Grunsven EG, Wanders RJA, Adamski J. Molecular basis of D-bifunctional protein deficiency. Mol Cell Endocrinol 2001; 171:61-70.

3. Martínez M. Sintomatología clínica de las enfermedades peroxisomales generalizadas. Rev Neurol 1999;28(1):S49-S54.

4. Wanders RJA, Barth PG, Heymans HSA. Single peroxisomal enzyme deficiencies. En: Scriver, Beaudet, Valle, Sly, editors. The metabolic and molecular bases of inherited disease. Eight edition. New York, USA: McGrawHill; 2001. p. 3219-3256.

5. Baumgartner MR, Verhooeven NM, Jacobs C, Roels F, Espeel M, Martínez M, et al. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdning-Hoffman disease. Neurology 1998;51:1427-1432.

6. Van Grunsven EG, van Berke E, Mooijer PAW, Watkins PA, Moser HW, Susuki Y, et al. Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am J Hum Genet 1999;64:99-107.

7. Moser HW. El peroxisoma: estructura, función y biogénesis. Rev Neurol 1999;28(1):S37-S39.

8. Van der Zand A, Braakman I, Geuze HJ, Tabak HF. The return of the peroxisomes. J Cell Sci 2006;119:989-994.

9. Ferdinandusse S, Ylianttila MS, Gloerich J, Koski K, Oostheim W, Waterham HR, et al. Mutational spectrum of D-bifunctional protein deficiency and structure based genotype-phenotype analysis. Am J Hum Genet 2006;78:112-124.

10. Gloerich J, Denis S, Van Grunsven EG, Dacremont G, Wanders RJ, Ferdinandusses S. A novel HPLC-based method to diagnose peroxisomal Dbifunctional protein enoyl-CoA hidratase deficiency. J Lipid Res 2003;44: 2714-2723.

11. Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, et al. Distinction between peroxisomal bifunctional enzyme and acyl-coA oxidase deficiencies. Ann Neurol 1995; 38:472-477.

12. Clayton PT. Clinical consequences of defects in peroxisomal β-oxidation. Biochemical Society 2001; 29(2):298-305.

13. Chang Ch-Ch, South S, Warren D, Jones J, Moser AB, Moser H, Gould SJ. Metabolic control of peroxisome abundance. J Cell Sci 1999;112: 1579-1590.

14. Moser HW. Estrategias terapéuticas para las enfermedades peroxisomales. Rev Neurol 1999; 28(1):S65-S69.

15. Martínez M, Vázquez E, García-Silva MT, Beltrán JM, Castelló F, Pineda M, et al. Tratamiento de las enfermedades peroxisomales generalizadas con etil éster del ácido docosahexaenoico. Rev Neurol 1999;28(1):S59-S64.

16. Paton BC, Solly PB, Nelson PV, Pollard NA, Sharp PC, Fietz MJ. Molecular analysis of genomic DNA allows rapid, and accurate, prenatal diagnosis of peroxisomal D-bifunctional protein deficiency. Prenat Diagn 2002;22:38-41.